Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 24, 2017

DrugPatentWatch Database Preview

Decitabine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for decitabine and what is the scope of freedom to operate?

Decitabine
is the generic ingredient in two branded drugs marketed by Dr Reddys Labs Ltd, Sandoz Inc, Accord Hlthcare, Sun Pharma Global, and Otsuka Pharm Co Ltd, and is included in five NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are sixteen drug master file entries for decitabine. Seven suppliers are listed for this compound.

Summary for Generic Name: decitabine

Tradenames:2
Patents:1
Applicants:5
NDAs:5
Drug Master File Entries: see list16
Suppliers / Packagers: see list7
Bulk Api Vendors: see list66
Clinical Trials: see list117
Patent Applications: see list6,630
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:decitabine at DailyMed

Pharmacology for Ingredient: decitabine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dr Reddys Labs Ltd
DECITABINE
decitabine
INJECTABLE;INTRAVENOUS203131-001Jul 11, 2013APRXNoNo► Subscribe► Subscribe
Otsuka Pharm Co Ltd
DACOGEN
decitabine
INJECTABLE;INTRAVENOUS021790-001May 2, 2006APRXYesYes► Subscribe► Subscribe
Accord Hlthcare
DECITABINE
decitabine
INJECTABLE;INTRAVENOUS203475-001Feb 27, 2017APRXNoNo► Subscribe► Subscribe
Sun Pharma Global
DECITABINE
decitabine
POWDER;INTRAVENOUS205582-001Jan 28, 2014RXYesYes► Subscribe► Subscribe
Sandoz Inc
DECITABINE
decitabine
INJECTABLE;INTRAVENOUS202969-001Aug 28, 2014APRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Identify first generic entrants
  • Uncover prior art in abandoned patent applications and expired patents
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot